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Abstract Transient neonatal diabe-
tes and neonatal hyperglycaemia 
both present in the neonatal period 
with features of hyperglycaemia, 
dehydration and weight loss. Dif-
ferentiating these conditions clini-
cally is difficult. We describe the 
case of a 13 day old female whom 
we managed recently who could 
have had either condition. Hyper-
glycaemia is not as commonly docu-
mented as would be expected for the 
frequency of neonatal disease and 
when it does occur, it will worsen 
neonatal morbidity and mortality. 
Blood glucose levels in babies on 
dextrose infusion should be moni-
tored regularly in order to help indi-
vidualise glucose requirements. 
Introduction 
 
Neonatal hyperglcaemia has been defined by various 
authors, with slightly different blood glucose levels. 
Digiacomo1 et al defines neonatal hyperglycaemia as a 
blood sugar greater than 8.3mmol/L in preterm babies, 
and blood sugar greater than 6.9mmol/L in term babies. 
Kallapur2 et al defines neonatal hyperglycaemia as a 
blood sugar level above 6.9mmol/L following a 4 hour 
fast in neonates.  Hyperglycaemia may coexist with a 
number of clinical conditions in the neonatal period 
though, more commonly, hypoglycaemia is likely to 
exist.  
 
Two clinical entities, somewhat similar in presentation 
and treatment but differing in aetiology and prognosis, 
present with hyperglycaemia in the newborn period; 
neonatal diabetes and transient neonatal hyperglycae-
mia. Both conditions present with hyperglycaemia with 
severe dehydration, glycosuria, and absent ketonuria2,3 
usually on a background of a septicaemia.4 The condi-
tions are differentiated with serum insulin studies, l vels 
being normal in the baby with transient neonatal hyper-
glycaemia. 
 
The case below highlights an encounter with a neonat  
who could have had either of both conditions. Unfortu-
nately, our inability to perform a serum insulin ass y, 
and the continued deterioration until eventual demis  of 
this infant, left us without a definite diagnosis. This case 
is highlighted so that we may realise the contributory 
effect that hyperglycaemia, when present, has to neona-




Baby ST was a 13 day old female delivered at a gesta-
tional age of 38 weeks, birth weight 2.5kg. She pre-
sented with a 12 hour history of refusal of feeds and 
seizures, which were noted at presentation. There was 
no history of fever, diarrhoea or vomiting and she was 
being exclusively breast fed; frequency and adequacy of 
feeds were apparently appropriate. Seizure was general-
ized tonic and was aborted with paraldehyde. The baby 
was delivered at the Teaching Hospital after 8 hours of 
labour, and there was no history suggestive of perinatal 
asphyxia. The mother is a 22 year old primiparous who 
attended ANC at the Teaching Hospital. Duration of 
pregnancy was not adversely eventful. 
 
On examination, she was acutely ill looking with a wiz-
ened facie, she was severely dehydrated, febrile 
(38.80C), with poor peripheral perfusion and with fea-
tures of a chest infection. Weight at admission was 
1.4kg (56% of birth weight), OFC 35cm, and length 
48cm. Investigations revealed a random blood sugar of 
20.1mmol/L (glucometer), 18.7mmol/L (glucose oxi-
dase); PCV 55%, Platelets 180x1012/L, WBC 14.8x109/L 
with polymorphs 46%, lymphocytes 42%; Serum elec-
trolytes Na 133mmol/L, K 3.1mmol/L; BUN  Urea 
18.9mmol/L, Creatinine 224mmol/L. Urine showed + 
glucose but no ketones. The assessment made at this 
time was that of a 13 day old term female with Primary 
Failure to Thrive, with Sepsis and an Acute Renal Ijury 
complicating dehydration. At that time she was too ill to 
have a lumbar puncture done. She received two boluses 
of normal saline at 20ml/kg/dose over the first two 
hours. At the end of the second bolus she made 2ml of 
urine and, her random blood glucose (RBS with the glu-
cometer) was now 19.7mmol/L.  
She continued on normal saline at 15% deficit minus 
anti-shock. A repeat RBS an hour later showed 
17.3mmol/L. At this point she was commenced on solu-
ble insulin at 0.05IU/kg/hr3 as hourly boluses. Intrave-
nous Ceftazidime was commenced and 2hourly RBS 
estimations continued. Nine hours after admission RBS 
dropped to 12.6mmol/L; at this time intravenous fluids 
were changed to 4.3% dextrose in 0.18 saline. Two 
hours later, blood glucose dropped to 9.8mmol/L and
remained between 7.8 and 10.4mmol/L over the next 8 
hours. Insulin studies were not done as facilities for this 
are unavailable in this environment. 
 
At 38hr on admission, her clinical condition was found 
to have deteriorated, with temperature instability, dimin-
ished peripheral pulses, and worsening peripheral perfu-
sion in spite of adequate hydration. Blood sugar fluctu-
ated between 11.0 and 15.9mmol/L. At this point we 
assumed that Systemic Inflammatory Response Syn-
drome had set in and started her on dopamine at 5µg/kg/
min. The two-hourly blood glucose estimation and intra-
venous insulin continued. From about the 47 hour on 
admission, blood glucose was noted to have begun to 
decline, falling to 8.0mmol/L; at that time the insulin 
dose was skipped. She died at the 63 hour on admission 
and it was noted that the final two readings before her 
demise were within normal limits (3.6mmol/L and 
2.8mmol/L).  
 
A post-mortem lumbar puncture revealed bloody CSF 
on macroscopic appearance. Microscopically, RBC were 
numerous, 30 WBC/cmm3 with 20% lymphocytes and 
80% PMN, no growth on culture. Her parents unfortu-






Hyperglycaemia is thought to be associated with a num-
ber of primary pathologic conditions [infection, as-
phyxia, hyperosmolality (following hyperosmolar feeds 
or hypernatraemic dehydration), seizures, respiratory 
distress]2,5 and drugs [steroids, β2 agonists, phenytoin, 
theophylline, intravenous glucose infusion]5 used in the 
neonatal period. It is also more common in the preterm 
and intrauterine growth restricted (IUGR) infant, as they 
appear to have a reduced capacity for insulin secretion.6 
In clinical practice, hyperglycaemia mostly occurs fol-
lowing the introduction of glucose containing intrave-
nous fluids, and responds appropriately to a reduction in 
the glucose concentration of the infusion. The evidnce 
for hyperglycaemia occurring with or as a complication 
of other clinical entities are few; Nalini et al5 working 
with 1171 neonates found a prevalence of 0.94% 
(prevalence in very low birth weight babies was 2.9%), 
in this environment documentation of the occurrence of 
hyperglycaemia occurring with/complicating primary 
morbidities is nonexistent. Give the frequency of neo a-
tal illness, it is either this problem does not occur, or is 
poorly documented when it does occur.  
 
Neonatal diabetes can also cause neonatal hyperglycae-
mia. It is defined as persistent hyperglycaemia occurring 
in the first months of life, lasting for more than 2 weeks 
and requiring insulin for management.7 It is considered 
distinct from autoimmune type 1 DM, which manifests 
after the first 3 to 6 months of life.8 It is a rare disorder, 
occurring in only 1:500,000 live births,7 and may be 
permanent or transient with/without recurrences.9 The 
condition was first described in the infant son of a physi-
cian who presented with polydypsia, polyphagia, polyu-
ria, dry skin after birth.3 It is characterised by hypergly-
caemia, glycosuria, hypoinsulinnaemia and absent or 
minimal ketonuria. Babies are usually full term, small 
for gestational age, and described as having an aged 
appearance and alert facies.10 Babies with the transient 
form respond to insulin with normalization of growth 
and weight gain, and remission is usually apparent by 
about the 3rd month of life.11 In majority of cases, the 
child relapses at about the age of puberty (median age 
14 years) with type 2 (nonautoimmune) diabetes.11 
Growth and development however remain normal. In the 
permanent form (about half of babies presenting with 
neonatal diabetes), insulin therapy is needed for life.12  
 
In the case of the neonate highlighted, she presentd 
with clear features of failure to thrive, with sepsis and 
dehydration. In majority of instances, in our clinical 
experience, the result of a random blood sugar done at 
admission would usually require for hypoglycaemia to 
be corrected. The finding of hyperglycaemia in the dia-
betic range is indeed a rare occurrence, and for that rea-
son insulin is not one of the usual drugs in the NICU 
emergency arsenal. 
 
Treatment of the underlying cause is usually sufficient 
to correct hyperglycaemia in neonates with transient 
neonatal hyperglycaemia. Unfortunately in this case, w  
lost the opportunity to arrive at a definitive diagnosis/
arrive at a definite cause of the hyperglycaemia as the 
baby gave in early into the primary pathology, and we 
lacked the capacity to run serum insulin assay. Rever-
sion of her blood glucose to near normal levels termi-







Hyperglycaemia, though not a primary diagnosis on its 
own, is capable of worsening morbidity and mortality. I  
therefore needs to be handled as a separate entity with 
insulin therapy. In the case highlighted, while notgiving 
total credence to the hyperglycaemia, it is certain hat it 
contributed to poor outcome. As has been previously 
stated, it is more common for hypoglycaemia to be the 
co-morbid finding at admission of most sick neonates. 
The finding of hyperglycaemia, demonstrated here, fur-
ther buttresses the need for random blood sugar estima-
tion to become part of routine admission work-up.  
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Taking into cognisance that hyperglycaemia is more 
likely to occur in babies on intravenous glucose infu-
sion, it may become necessary, as a matter of princi le, 
to check blood glucose levels in babies in dextrose infu-
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